Cite
De Tursi M, Zilli M, Carella C, et al. Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. Onco Targets Ther. 2017;10:3007-3015doi: 10.2147/OTT.S127795.
De Tursi, M., Zilli, M., Carella, C., Auriemma, M., Lisco, M. N., Di Nicola, M., Di Martino, G., Natoli, C., & Amerio, P. (2017). Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. OncoTargets and therapy, 103007-3015. https://doi.org/10.2147/OTT.S127795
De Tursi, Michele, et al. "Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts." OncoTargets and therapy vol. 10 (2017): 3007-3015. doi: https://doi.org/10.2147/OTT.S127795
De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P. Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts. Onco Targets Ther. 2017 Jun 16;10:3007-3015. doi: 10.2147/OTT.S127795. eCollection 2017. PMID: 28670133; PMCID: PMC5481280.
Copy
Download .nbib